ReaScan CXCL13 provides a new diagnostic tool for the rapid determination of CXCL13 and helps clinicians in the treatment decision for suspected Lyme neuroborreliosis (LNB) patients. The test result is read from the test cassette with the ReaScan+ reader. The test is intended for in vitro diagnostic laboratory use by healthcare professionals.
Specificity 96 % Sensitivity 100 % with cut-off 250 pg/mL
Order Code: 114253
Reading of the result:
ReaScan+ reader is sold separately (105100)